Literature DB >> 11099282

Using the modified Barthel index to estimate survival in cancer patients in hospice: observational study.

M Bennett1, N Ryall.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 11099282      PMCID： PMC27540          DOI： 10.1136/bmj.321.7273.1381

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Improving the sensitivity of the Barthel Index for stroke rehabilitation.

Authors:  S Shah; F Vanclay; B Cooper
Journal:  J Clin Epidemiol       Date:  1989       Impact factor: 6.437

2.  Prognostic uncertainty in terminal care: can the Karnofsky index help?

Authors:  C Evans; M McCarthy
Journal:  Lancet       Date:  1985-05-25       Impact factor: 79.321

3.  Evaluation of patients with advanced cancer using the Karnofsky performance status.

Authors:  J W Yates; B Chalmer; F P McKegney
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860
  3 in total
  16 in total

Review 1.  A framework for assessment in oncology rehabilitation.

Authors:  Laura S Gilchrist; Mary Lou Galantino; Meredith Wampler; Victoria G Marchese; G Stephen Morris; Kirsten K Ness
Journal:  Phys Ther       Date:  2009-01-15

2.  Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome.

Authors:  Barbara Deschler; Gabriele Ihorst; Uwe Platzbecker; Ulrich Germing; Eva März; Marcelo de Figuerido; Kurt Fritzsche; Peter Haas; Helmut R Salih; Aristoteles Giagounidis; Dominik Selleslag; Boris Labar; Theo de Witte; Pierre Wijermans; Michael Lübbert
Journal:  Haematologica       Date:  2012-08-08       Impact factor: 9.941

3.  Functional independence, diagnostic groups, hospital stay, and modality of payment in three Croatian seaside inpatient rehabilitation centers.

Authors:  Nada Tomasović Mrčela; Dražen Massari; Tonko Vlak
Journal:  Croat Med J       Date:  2010-12       Impact factor: 1.351

4.  The terminal phase of life as a team-based clinical global judgment: prevalence and associations in an acute geriatric unit.

Authors:  H Frohnhofen; O Hagen; H C Heuer; C Falkenhahn; P Willschrei; H G Nehen
Journal:  Z Gerontol Geriatr       Date:  2011-10       Impact factor: 1.281

5.  Using the Barthel Index to Assess Activities of Daily Living after Musculoskeletal Tumour Surgery: A Single-centre Observational Study.

Authors:  Masanori Okamoto; Munehisa Kito; Yasuo Yoshimura; Kaoru Aoki; Shuichiro Suzuki; Atsushi Tanaka; Akira Takazawa; Kazushige Yoshida; Yoshikazu Ido; Takaaki Ishida; Keiko Kawasaki; Hiroyuki Kato
Journal:  Prog Rehabil Med       Date:  2019-03-26

6.  Functional recovery measures for spinal cord injury: an evidence-based review for clinical practice and research.

Authors:  Kim Anderson; Sergio Aito; Michal Atkins; Fin Biering-Sørensen; Susan Charlifue; Armin Curt; John Ditunno; Clive Glass; Ralph Marino; Ruth Marshall; Mary Jane Mulcahey; Marcel Post; Gordana Savic; Giorgio Scivoletto; Amiram Catz
Journal:  J Spinal Cord Med       Date:  2008       Impact factor: 1.985

7.  [Diagnostic and treatment goals in elderly patients].

Authors:  A H Leischker; G F Kolb
Journal:  Internist (Berl)       Date:  2007-11       Impact factor: 0.743

8.  The Australia-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice [ISRCTN81117481].

Authors:  Amy P Abernethy; Tania Shelby-James; Belinda S Fazekas; David Woods; David C Currow
Journal:  BMC Palliat Care       Date:  2005-11-12       Impact factor: 3.234

9.  Accuracy of prognosis estimates by four palliative care teams: a prospective cohort study.

Authors:  Irene J Higginson; Massimo Costantini
Journal:  BMC Palliat Care       Date:  2002       Impact factor: 3.234

10.  The systemic inflammatory response, performance status and survival in patients undergoing alpha-interferon treatment for advanced renal cancer.

Authors:  E Bromwich; D C McMillan; G W A Lamb; P A Vasey; M Aitchison
Journal:  Br J Cancer       Date:  2004-10-04       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.